5/17/2024  9:59:58 PM Chg. -0.75 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
104.12USD -0.72% 237,996
Turnover: 24.79 mill.
-Bid Size: - -Ask Size: - 181.08 bill.USD 2.00% 31.73

Business description

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 160 countries.
 

Management board & Supervisory board

CEO
Robert B. Ford, Daniel Salvadori
Management board
Robert E. Funck, Jr., Hubert L. Allen, John M. Capek, Lisa D. Earnhardt, John F. Ginascol, Joseph Manning, Mary K. Moreland, Andrea Wainer, Gregory A. Ahlberg, Christopher J. Calamari, Michael D. Dale, J. Scott House, Sammy Karam, Fernando Mateus, Louis H. Morrone, Michael J. Pederson, Julie L. Tyler, Jared L. Watkin, Alejandro D. Wellisch, Randel W. Woodgrift
Supervisory board
Robert B. Ford, Daniel J. Starks, Darren W. McDew, Dr. Sally E. Blount, John G. Stratton, Michael F. Roman, Michelle A. Kumbier, Nancy McKinstry, Robert J. Alpern, Claire Babineaux-Fontenot, William A. Osborn, Glenn F. Tilton, Paola Gonzalez
 

Company data

Name: Abbott Laboratories
Address: 100 Abbott Park Road,Abbott Park Illinois, Chicago 60064-3500, USA
Phone: +1-224-667-6100
Fax: -
E-mail: -
Internet: www.abbott.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 87.10%
IPO date: 6/1/1972

Investor relations

Name: Scott Leinenweber
IR phone: +1-224-667-8945
IR Fax: -
IR e-mail: -

Main Shareholders

Others
 
63.69%
Vanguard Group, Inc.
 
8.95%
Blackrock Inc.
 
7.80%
Capital Research Global Investors
 
4.39%
State Street Corporation
 
4.22%
Capital International Investors
 
3.25%
Morgan Stanley
 
2.11%
Geode Capital Management, LLC
 
1.79%
Northern Trust Corporation
 
1.38%
Others
 
2.42%